Is TNBC up or down today?
TNBC is up 1.31% today, last at 163.92. This stock moved +1.31% versus the prior close.
TNBC · TNBC
TNBC (TNBC) is trading at 163.92, up 1.31% on the session. Price signals are mixed — no clear one-way momentum read.
Over the past 7 days, 3 headlines skew mixed. Macro/Market stories led the conversation.
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
TNBC is up 1.31% today, last at 163.92. This stock moved +1.31% versus the prior close.
Over the past 7 days, 3 headlines skew mixed. Macro/Market stories led the conversation. Dominant story: Kazia Therapeutics Files Provisional Patent Backing New Paxalisib Strategy in High-Risk Early TNBC - TipRanks (1 source, bullish) RSI unavailable Price sits at 50% of its 52-week range Social (demo): 44% of recent mentions lean bullish — mixed social mood.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
Analyst firms are mostly reiterating — no strong directional shift lately.
Query: TNBC
38/ 100 index
-40.6% vs start of window
Based on 11,670 mentions over 30d
Kazia Therapeutics Files Provisional Patent Backing New Paxalisib Strategy in High-Risk Early TNBC - TipRanks
Kazia Therapeutics (NASDAQ: KZIA) files patent backed by TNBC data - Stock Titan
CHMP Recommends Sacituzumab Govitecan Plus Pembrolizumab for Frontline PD-L1+ Metastatic TNBC - OncLive
Will Trodelvy’s First-Line TNBC Approval Redefine Gilead Sciences’ (GILD) Oncology-Led Investment Narrative? - Yahoo Finance
Gilead Wins EC Approval to Expand Trodelvy's Label in Metastatic TNBC - Yahoo Finance